Back
Catalyst Pharmaceuticals Vs. Innodata Industry Stock Comparison
Buy
62
CPRX
Catalyst Pharmaceuticals
Last Price:
$21.64
Seasonality Move:
32.03%
Buy
60
INOD
Innodata
Last Price:
$50.37
Seasonality Move:
11.17%
Buy
62
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
-
The current Catalyst Pharmaceuticals [CPRX] share price is $21.81. The Score for CPRX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
CPRX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $21.81Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing slight buying pressure.
CPRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 42.37 | Sell |
Chaikin Money Flow: | 199836 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.16 - 24.52) | Sell |
Bollinger Bands (100): | (21.73 - 24.57) | Sell |
INOD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 11.39 | Buy |
Relative Strength Index (14 RSI): | 54.81 | Buy |
Chaikin Money Flow: | -1218826 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.16 - 51.14) | Buy |
Bollinger Bands (100): | (35.62 - 50.5) | Buy |
CPRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.39 | Buy |
20-day SMA: | 22.11 | Sell |
50-day SMA: | 23.53 | Sell |
200-day SMA: | 22.4 | Sell |
8-day EMA: | 21.6 | Buy |
20-day EMA: | 22.18 | Sell |
50-day EMA: | 21.97 | Sell |
200-day EMA: | 12.67 | Buy |
INOD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.23 | Sell |
20-day SMA: | 47.99 | Buy |
50-day SMA: | 43 | Buy |
200-day SMA: | 37.6 | Buy |
8-day EMA: | 32.48 | Buy |
20-day EMA: | 16.93 | Buy |
50-day EMA: | 7.59 | Buy |
200-day EMA: | 2.01 | Buy |
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.17 per share, an increase this year of $0.04 per share, and an increase next year of $0.25 per share.
Innodata Earnings Growth & INOD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.06 per share, and an increase next year of $0.40 per share.
Catalyst Pharmaceuticals Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Innodata Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |